Vaxcyte, Inc. PCVX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Vaxcyte, Inc.’s reported figures.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s free cash flow?
- Vaxcyte, Inc. (PCVX) reported free cash flow of -$282.73M in Q1 2026.
- How has Vaxcyte, Inc.'s free cash flow changed year-over-year?
- Vaxcyte, Inc.'s free cash flow decreased by 64.7% year-over-year, from -$171.7M to -$282.73M.
- What is the long-term trend for Vaxcyte, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s free cash flow has grown at a 51.2% compound annual growth rate (CAGR), from -$127.95M to -$669.29M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.